Research Article
Integrative Bioinformatics Analysis Identifies DDX60 as a Potential Biomarker for Systemic Lupus Erythematosus
Figure 4
DDX60 expression levels in different subgroups of the SLE Disease Activity Index (SLEDAI) and anti-dsDNA in blood samples. ; ; ns: no statistically significant difference (). (a) DDX60 expression level of patients with systemic lupus erythematosus (SLE) was significantly higher than that of healthy controls (HCs) (). (b) DDX60 expression level of patients with positive anti-dsDNA antibody was higher than that of patients with negative dsDNA antibody. (c) No significant difference () of DDX60 expression level was observed between patients with and patients with SLEDAI from 0 to 4.
(a) |
(b) |
(c) |